Bayer, a German manufacturer of pharmaceuticals and agrochemicals, said that a jury in California, USA, concluded that its herb Roundup did not cause cancer in a woman. The company has secured a second trial victory for its defensive glyphosate, after a jury in Los Angeles (US) first ruled in Bayer’s favor in October. Earlier, Bayer had lost three cases related to Roundup.
The San Bernardino court ruled in favor of the company when the victim said she had contracted non-Hodgkin’s lymphoma after using Roundup herbicide for more than 30 years. “The jury’s decision brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer,” a Bayer spokesperson said.
Bayer claims that Roundup, which it bought from US agrochemical company Monsanto for $63 billion, does not cause cancer. Germany-based company Leverkusen hopes a US Supreme Court ruling in a separate case will help end the herb’s years-long litigation. The legal issues surrounding Roundup prompted the company to set aside billions in provisions to resolve the cases.
Read more about companies and businesses